Drug screening model taking histidine kinase AgrC as target spot
A histidine kinase and drug technology, applied in the field of biomedicine, to achieve the effects of convenient operation, strong specificity and clear action site
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0034] The technical solutions of the present invention will be further described below in conjunction with specific examples, but the present invention is not limited by the content of the examples in any form. Unless otherwise specified, the test methods described in the examples are conventional methods; unless otherwise specified, the reagents and biological materials can be obtained from commercial sources.
[0035] Escherichia coli strains were purchased from Novagen, Escherichia coli strains BL21(DE3), Tuner(DE3), C41(DE3), C43(DE3), BL21(DE3)-pLysS and BL21-CodonPlus(DE3)-RIL were all acceptable. For the expression of AgrC protein, preferably C43(DE3). The purpose of choosing six Escherichia coli as hosts to express AgrC protein is to investigate which strain has the highest expression level of AgrC protein. After screening, the expression level of AgrC protein in Escherichia coli strain C43 (DE3) was the highest, so this strain was used as a carrier for protein expre...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com